Abstract:Key PointsThe liver provides a useful generic model of inflammation and repair, showing the complex interplay between the epithelial, inflammatory, myofibroblast and extracellular matrix (ECM) components of the mammalian wound-healing response. In almost all situations, fibrosis is preceded by inflammation and elements of both the innate and adaptive immune systems are crucial in regulating the fibrotic process.Following liver injury, pro-inflammatory mediators that are generated by cellular damage and stimulated immune cells, as well as growth factors and cytokines (including platelet-derived growth factor, connective tissue growth factor, transforming growth factor-β and interleukin-13), activate mesenchymal precursor cells in tissues and induce their transdifferentiation into myofibroblasts. Myofibroblasts are master regulators of the fibrotic response as a result of their acquisition of scar-producing, proliferative, migratory, contractile, immunomodulatory and phagocytic properties.Recent studies have used bone marrow transplantation techniques in reporter mice to show that, regardless of the aetiology or the duration of the injury, liver myofibroblasts are almost exclusively derived from the activation of resident mesenchymal cells. Perpetuation of myofibroblast fibrogenic activity is mediated through several positive feedback loops, involving the autocrine and paracrine effects of cytokines and growth factors, and cell–cell and cell–matrix interactions. Myofibroblasts themselves function as innate immune cells.The balance of T helper 1 (TH1) cell-mediated and TH2 cell-mediated adaptive immune responses, the influence of unconventional T cell subsets and the equilibrium between different pro-inflammatory (that is, pro-fibrotic) and pro-resolution macrophage populations determine whether the outcome of tissue injury is homeostatic and self-limited or whether it results in pathogenic scarring.Liver fibrosis in rodents and humans is a dynamic, bidirectional process that has an inherent capacity for recovery and remodelling. The loss of myofibroblasts from the hepatic scar and a crucial switch in macrophage phenotype to a pro-resolution cell type are important events in the regression of liver fibrosis that facilitate remodelling of the ECM.A considerable number of tractable therapeutic targets have been identified in liver fibrosis, but clinical trials of anti-fibrotic therapies have so far been unsuccessful. Identification of the core pathways in fibrosis is likely to yield greater success in clinical translation.

Influence of Hepatic Innate Immunity on Liver Regeneration

The Roles Of Innate Immune Cells In Liver Injury And Regeneration

Role of the Portal System in Liver Regeneration: from Molecular Mechanisms to Clinical Management

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Immune cells in liver regeneration

Liver regeneration and inflammation: from fundamental science to clinical applications

Liver Regeneration in Chronic Liver Injuries: Basic and Clinical Applications Focusing on Macrophages and Natural Killer Cells

Liver fibrosis and repair: immune regulation of wound healing in a solid organ

Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis

Hepatic inflammation and fibrosis: Functional links and key pathways

Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations

The Hepatic Nerves Regulated Inflammatory Effect in the Process of Liver Injury: Is Nerve the Key Treating Target for Liver Inflammation?

Innate lymphocytes: pathogenesis and therapeutic targets of liver diseases and cancer

Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury

Liver: an Organ with Predominant Innate Immunity

Liver Regeneration: Changes in Oxidative Stress, Immune System, Cytokines, and Epigenetic Modifications Associated with Aging

Liver Injury and Regeneration: Current Understanding, New Approaches, and Future Perspectives

Hormonal Contribution to Liver Regeneration

The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis

Interorgan communication with the liver: novel mechanisms and therapeutic targets

Liver regeneration: Cellular origin and molecular mechanisms